Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.

Front Pharmacol · 2022 · PMC9234690 · PMID 35770100

Europe PMC DOI

hedged sentence

0.4510

closest p · 9.0× alpha

0.4510

boldest claim

The sentences

did not reach statistical significancep = 0.451not close (p > 0.1)

The mPFS was different among the mutation subtypes pure G719X and pure L861X, although the difference did not reach statistical significance (10.3 vs NR; p = 0.451) ( Figure 3E ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.